Actively Recruiting
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
Led by Herlev Hospital · Updated on 2025-11-26
300
Participants Needed
1
Research Sites
630 weeks
Total Duration
On this page
Sponsors
H
Herlev Hospital
Lead Sponsor
D
Danish Cancer Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
CONDITIONS
Official Title
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure
- Age of 18 years or above
- Signed informed consent form
You will not qualify if you...
- Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev og Gentofte Hospital
Herlev, Capital Region, Denmark, 2730
Actively Recruiting
Research Team
B
Bojan Kovacevic, ph.d., MD
CONTACT
L
Louise Maegaard, MSc, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here